EU Study Revives Industry Attacks On Promotion Of Off-Label Use To Save Money
Executive Summary
A study for the European Commission explores in detail the drivers behind off-label use of medicines in EU countries, but the pharmaceutical industry would have liked it to speak out against national authorities’ promotion of off-label uses for economic reasons.